HighTower Advisors
ASTH icon

HighTower Advisors’s Astrana Health ASTH Stock Holding History

HighTower Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,127
Closed -$1.58M – 4088
2024
Q4 		$1.58M Sell
50,127
-49,888
-50% -$2.37M ﹤0.01% 1659
2024
Q3 		$5.8M Sell
100,015
-31,195
-24% -$1.53M 0.01% 972
2024
Q2 		$5.32M Buy
131,210
+839
+0.6% +$33.3K 0.01% 979
2024
Q1 		$5.47M Sell
130,371
-40,726
-24% -$1.59M 0.01% 923
2023
Q4 		$6.55M Buy
171,097
+15
+0% +$499 0.01% 861
2023
Q3 		$5.28M Buy
171,082
+99,986
+141% +$3.45M 0.01% 905
2023
Q2 		$2.25M Buy
71,096
+10,620
+18% +$364K ﹤0.01% 1289
2023
Q1 		$2.21M Hold
60,476
– – ﹤0.01% 1229
2022
Q4 		$1.79M Hold
60,476
– – ﹤0.01% 1350
2022
Q3 		$2.36M Hold
60,476
– – 0.01% 1145
2022
Q2 		$2.33M Sell
60,476
-2,620
-4% -$99.7K 0.01% 1171
2022
Q1 		$3.06M Buy
63,096
+2,424
+4% +$125K 0.01% 1128
2021
Q4 		$4.46M Buy
60,672
+196
+0.3% +$16.1K 0.01% 959
2021
Q3 		$5.51M Buy
+60,476
New +$5.14M 0.01% 781

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HighTower Advisors's ASTH Position: Q1 2025 in Review

HighTower Advisors sold out of Astrana Health (ASTH) in Q1 2025, closing a stake of 50,127 shares — an estimated $1.58M sold.

HighTower Advisors first reported a position in ASTH in Q3 2021 and held it in 14 quarters. The position peaked at $6.55M in Q4 2023. 168 funds tracked by Wall St. Rank hold ASTH as of Q1 2025.

  • HighTower Advisors reported no remaining Astrana Health position as of Q1 2025 after selling out during the quarter.
  • HighTower Advisors sold 50,127 Astrana Health shares in Q1 2025, an estimated $1.58M.
  • HighTower Advisors first reported a position in Astrana Health in Q3 2021 and held it in 14 quarters.
  • HighTower Advisors's Astrana Health position peaked at $6.55M in Q4 2023.
  • 168 funds tracked by Wall St. Rank held Astrana Health as of Q1 2025.

Based on HighTower Advisors's 13F filing for Q1 2025, filed 13 May 2025.